Neng Tang

Neng Tang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2024 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
ZLZhecheng Li
Zhecheng Li
ZWZhaoyi Wu
Zhaoyi Wu
XYXing You
Xing You
NTNeng Tang
Neng Tang
TK1 (Thymidine kinase 1) is a member of the thymidine kinase family and has been observed to be significantly upregulated in a variety of cancer types. However, the exact roles of TK1 in tumor progression and the tumor immune microenvironment are not fully understood. This study aims to investigate the comprehensive involvement of TK1 in pan-cancer through the utilization of bioinformatics analysis, validation of pathological tissue samples, and in vitro experimental investigations. The expression profiles together with diagnostic and prognostic role of TK1 in pan-cancer were investigated though TCGA, TARGET, GTEx, and CPTAC databases. The single-sample gene set enrichment analysis (ssGSEA) and single-cell sequencing datasets were used to examine the relationship between TK1 and immune infiltration. The expression of TK1 were verified in hepatocellular carcinoma (HCC) through qPCR, western blotting and immunohistochemical assays. The proliferative capacity of HCC cell lines was assessed through CCK-8 and colony formation assays, while cytokine levels were measured via ELISA. Furthermore, flow cytometry was utilized to analyze cell cycle distribution and the proportions of Th2 cells. TK1 was overexpressed in most cancers and demonstrated significant diagnostic and prognostic value. Among the various immune cells in pan-cancer, Th2 cells exhibited the closest association with TK1. Furthermore, the single-cell atlas provided insights into the distribution and proportion of TK1 in immune cells of HCC. In vitro experiments revealed an elevated expression of TK1 in HCC tissue and cell lines, and its role in influencing HCC cell proliferation by regulating G0/G1 phase arrest. Additionally, TK1 in cancer cells was found to potentially modulate Th2 cell polarization through the chemokine CCL5. TK1 holds immense potential as a biomarker for pan-cancer diagnosis and prognosis. Additionally, targeting the expression of TK1 represents a promising therapeutic approach that can enhance the efficacy of current anti-tumor immunotherapy by modulating Th2 cell polarization and multiple mechanisms.

12 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HTHai-long Tan
Hai-long Tan
HGHuan Ge
Huan Ge
ZQZi-En Qin
Zi-En Qin
YJYa-Ling Jiang
Ya-Ling Jiang
SCShi Chang
Shi Chang
NTNeng Tang
Neng Tang
Hashimoto’s thyroiditis is the most common endocrine disorder, with diagnosis primarily relying on serum thyroid autoantibodies and ultrasound feature. However, the diagnostic accuracy of serum thyroid autoantibodies and ultrasound for Hashimoto’s thyroiditis remains unclear. This study enrolled 24,014 participants, including 6,195 (25.8%) patients diagnosed with Hashimoto’s thyroiditis. The diagnostic performance of ultrasound and serum thyroid autoantibodies was assessed against histopathological findings. Both serum thyroid autoantibodies and ultrasound demonstrated high overall specificity (91.8%, 89.8%, and 92.1%, respectively) and negative predictive value (87.4%, 86.9%, and 86.0%, respectively) for diagnosing Hashimoto’s thyroiditis. Additionally, thyroid autoantibodies level was strongly correlated with the risk of Hashimoto’s thyroiditis. However, these methods demonstrated low independent sensitivity (30.5%, 28.5%, and 22.9%, respectively) and positive predictive value (43.7%, 32.4%, and 28.5%, respectively). Furthermore, the combined use of these methods resulted in a notably low sensitivity of 33.6%, despite a relatively low false positive rate of 11.9%. Elevated thyroid autoantibodies strongly correlate with Hashimoto’s thyroiditis risk. While both autoantibodies and ultrasound demonstrate high specificity and negative predictive value, their low independent sensitivity and positive predictive value limit reliability. Combined use reduces false positives but further diminishes sensitivity.

27 August 2024 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
HTHai-Long Tan
Hai-Long Tan
ZQZi-En Qin
Zi-En Qin
SDSai-Li Duan
Sai-Li Duan
YJYa-Ling Jiang
Ya-Ling Jiang
NTNeng Tang
Neng Tang
SCShi Chang
Shi Chang
Although the potential association between autoimmune thyroiditis and papillary thyroid cancer (PTC) has been acknowledged, whether the clinicopathological features of PTC will be affected by thyroid autoantibodies remains unknown. We conducted a case-control study to investigate the association of thyroid autoantibodies with clinicopathological characteristics of PTC in 15,305 patients (including 11,465 females and 3,840 males) from 3 medical centers in the central province of China. Logistic regression and restricted cubic spline models were performed to analyze the association of thyroid autoantibodies with clinicopathological features of PTC. In total, out of the 15,305 patients enrolled in this study, 10,087 (65.9%) had negative thyroid autoantibodies, while 5,218(34.1%) tested positive thyroid autoantibodies. Among these individuals, 1,530(10.0%) showed positivity for TPOAb only, 1,247(8.2%) for TGAb only and a further 2,441(15.9%) exhibited dual positivity for both TPOAb and TGAb combined. Thyroid autoantibodies level demonstrated significant correlations with certain aggressive features in PTC. Specifically, TGAb level displayed a direct correlation to an increased likelihood of multifocality, bilateral tumor, extrathyroidal extension, lymph node metastasis, as well as more than five affected lymph nodes. However, TPOAb level exhibited an inverse association with the risk associated with extrathyroidal extension, lymph node metastasis, and more than five affected lymph nodes. Elevated level of TGAb were positively correlated with the risk of aggressive features in PTC, while high level of TPOAb were inversely associated with the risk of extrathyroidal extension and lymph node metastasis.